Mecaton

Diosmin, the active ingredient in Mecaton, is a flavonoid presented as an oral tablet for oral use. It is employed to support venous tone and microcirculation in adults with chronic venous insufficiency, hemorrhoidal disease, and varicose veins. Mecaton combines diosmin with hesperidin to provide a complementary flavonoid effect.

GNH USA supplies Mecaton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mecaton is a flavonoid preparation indicated for disorders of the venous system and related microcirculatory dysfunction.

- Chronic venous insufficiency: improves venous return and reduces leg swelling. - Hemorrhoids: alleviates bleeding, pain and inflammation of hemorrhoidal tissue. - Varicose veins: decreases vein distension and discomfort associated with varicosities.

Mecaton is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal discomfort: mild abdominal pain or upset stomach. - Nausea: occasional feeling of queasiness. - Headache: transient mild to moderate headache. - Dizziness: brief episodes of light‑headedness. - Skin rash: mild erythematous eruption. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hepatic dysfunction: signs of liver injury such as jaundice or elevated enzymes. - Blood clotting disorders: unexpected bruising or prolonged bleeding. - Stevens‑Johnson syndrome: rare severe skin reaction. - Acute renal impairment: sudden decrease in kidney function. - Thrombocytopenia: markedly reduced platelet count.

Before initiating Mecaton, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Renal impairment: monitor kidney function and adjust use if needed. - Underlying bleeding disorders: assess risk of increased bleeding. - Concomitant anticoagulant therapy: evaluate bleeding risk closely. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mecaton may interact with other medicines; review all concomitant drugs.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may potentiate bleeding risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole): could increase flavonoid plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs: additive gastrointestinal irritation. - Diuretics: possible electrolyte disturbances. - Antihypertensives: potential additive blood‑pressure lowering effect. - Antiplatelet agents: monitor for enhanced antithrombotic activity.